Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From Investor Relations...

12-14-12

Dear _______

Upon further review with our litigation counsel we have been advised against issuing a PR at this time given that the summary ruling was not a complete ruling, and that it may be followed by such at a later date.

Regards,

GLTAL!

Yaz


Dec 14, 2012 04:54PM
6
Dec 14, 2012 05:00PM
Share
New Message
Please login to post a reply